Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to assess the efficacy of atropine in preventing nausea and vomiting after spinal anesthesia with local anesthetic and morphine for elective Caesarean section.

Patients enrolling in the study will be assigned to one of three groups. One will receive a small dose of intrathecal atropine; another will receive small-dose intravenous atropine; the third group will receive placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Parma
• Treatments: Anesthetics; Anesthetics, Local; Antiemetics; Atropine; Bupivacaine; Morphine; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Patients scheduled for elective Cesarean section at up to 42 weeks and 2 days

• Patients in ASA Physical Status Class I or II

• Informed written consent to participation

• No known gestosis

Exclusion Criteria:

• Any known fetal pathology

• Indication to general anesthesia

• Known allergy to any of the study drugs

• Baseline bradycardia or any cardiovascular disease